{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:58:16Z","timestamp":1787497096071,"version":"build-2736575974"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2017-1734\/PICT 2015-3861"],"award-info":[{"award-number":["PICT 2017-1734\/PICT 2015-3861"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Biotechnology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.copbio.2020.09.005","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T13:35:34Z","timestamp":1602164134000},"page":"8-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Genetic manipulation of phages for therapy using BRED"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7462-476X","authenticated-orcid":false,"given":"Florencia","family":"Payaslian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Gradaschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Piuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.copbio.2020.09.005_bib0005","first-page":"10","article-title":"Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review","author":"Mulani","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.copbio.2020.09.005_bib0010","series-title":"Antimicrobial resistance","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.copbio.2020.09.005_sbref0015","first-page":"66","article-title":"Tailored antibacterials and innovative laboratories for phage (\u03a6) research: personalized infectious disease medicine for the most vulnerable at-risk patients","volume":"1","author":"Terwilliger","year":"2020","journal-title":"Phage"},{"key":"10.1016\/j.copbio.2020.09.005_sbref0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.00066-18","article-title":"Phage therapy in the postantibiotic era","volume":"32","author":"Gordillo Altamirano","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.copbio.2020.09.005_sbref0025","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.tim.2018.09.006","article-title":"Engineering bacteriophages as versatile biologics","volume":"27","author":"Kilcher","year":"2019","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.copbio.2020.09.005_sbref0030","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1128\/MMBR.00069-15","article-title":"Genetically engineered phages: a review of advances over the last decade","volume":"80","author":"Pires","year":"2016","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.copbio.2020.09.005_sbref0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003957","article-title":"BRED: a simple and powerful tool for constructing mutant and recombinant bacteriophage genomes","volume":"3","author":"Marinelli","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.copbio.2020.09.005_bib0040","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","article-title":"Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus","volume":"25","author":"Dedrick","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.copbio.2020.09.005_bib0045","doi-asserted-by":"crossref","first-page":"8111","DOI":"10.1128\/JVI.03003-14","article-title":"Innovations in undergraduate science education: going viral","volume":"89","author":"Hatfull","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.copbio.2020.09.005_bib0050","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.molcel.2012.11.012","article-title":"Integration-dependent bacteriophage immunity provides insights into the evolution of genetic switches","volume":"49","author":"Broussard","year":"2013","journal-title":"Mol Cell"},{"key":"10.1016\/j.copbio.2020.09.005_sbref0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2019.01.002","article-title":"Mycobacteriophage ZoeJ: a broad host-range close relative of mycobacteriophage TM4","author":"Dedrick","year":"2019","journal-title":"Tuberculosis"},{"key":"10.1016\/j.copbio.2020.09.005_bib0060","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1126\/science.364.6440.518","article-title":"Engineered phages stymie drug-resistant infection","volume":"364","author":"Fox","year":"2019","journal-title":"Science (80-)"},{"key":"10.1016\/j.copbio.2020.09.005_sbref0065","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.genet.36.061102.093104","article-title":"Genetic engineering using homologous Recombination","volume":"36","author":"Court","year":"2002","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.copbio.2020.09.005_bib0070","first-page":"1","article-title":"Recombineering: genetic engineering in bacteria using homologous recombination","volume":"16","author":"Thomason","year":"2014","journal-title":"Curr Protoc Mol Biol"},{"key":"10.1016\/j.copbio.2020.09.005_bib0075","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/iub.2343","article-title":"Half a century of bacteriophage lambda recombinase : in vitro studies of lambda exonuclease and Red-beta annealase","volume":"72","author":"Brewster","year":"2020","journal-title":"IUBMB Life"},{"key":"10.1016\/j.copbio.2020.09.005_bib0080","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pbiomolbio.2019.03.005","article-title":"Structure and mechanism of the Red recombination system of bacteriophage \u03bb","volume":"147","author":"Caldwell","year":"2019","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.copbio.2020.09.005_bib0085","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1365-2958.2008.06109.x","article-title":"Efficient point mutagenesis in mycobacteria using single-stranded DNA recombineering: characterization of antimycobacterial drug targets","volume":"67","author":"van Kessel","year":"2008","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.copbio.2020.09.005_bib0090","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nmeth996","article-title":"Recombineering in Mycobacterium tuberculosis","volume":"4","author":"van Kessel","year":"2007","journal-title":"Nat Methods"},{"key":"10.1016\/j.copbio.2020.09.005_sbref0095","first-page":"903","article-title":"Hatfull and Mariana Piuri: recombineering: a powerful tool for modification of bacteriophage genomes","volume":"23","author":"Marinelli","year":"2012","journal-title":"Bacteriophage"},{"key":"10.1016\/j.copbio.2020.09.005_sbref0100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-1-4939-8940-9_6","article-title":"Genetic manipulation of lytic bacteriophages with BRED: bacteriophage recombineering of electroporated DNA","volume":"1898","author":"Marinelli","year":"2019","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.copbio.2020.09.005_bib0105","first-page":"10","article-title":"Phage genetic engineering using CRISPR?Cas systems","author":"Hatoum-Aslan","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.copbio.2020.09.005_bib0110","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4161\/rna.27766","article-title":"Efficient engineering of a bacteriophage genome using the type I-E CRISPR-Cas system","volume":"11","author":"Kiro","year":"2014","journal-title":"RNA Biol"},{"key":"10.1016\/j.copbio.2020.09.005_bib0115","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1038\/ismej.2016.47","article-title":"Genetic and life-history traits associated with the distribution of prophages in bacteria","volume":"10","author":"Touchon","year":"2016","journal-title":"ISME J"},{"key":"10.1016\/j.copbio.2020.09.005_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2014.00184","article-title":"Clostridium difficile phages: still difficult?","volume":"5","author":"Hargreaves","year":"2014","journal-title":"Front Microbiol"},{"key":"10.1016\/j.copbio.2020.09.005_bib0125","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.tim.2018.10.008","article-title":"Phage therapy: going temperate?","volume":"27","author":"Monteiro","year":"2019","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.copbio.2020.09.005_bib0130","first-page":"11","article-title":"In vivo targeting of Clostridioides difficile using phage- delivered CRISPR-Cas3 antimicrobials","author":"Selle","year":"2020","journal-title":"MBio"},{"key":"10.1016\/j.copbio.2020.09.005_bib0135","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cels.2015.08.013","article-title":"Engineering modular viral scaffolds for targeted bacterial population editing","volume":"1","author":"Ando","year":"2015","journal-title":"Cell Syst"},{"key":"10.1016\/j.copbio.2020.09.005_bib0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.09.062","article-title":"Reprogramming bacteriophage host range through structure-guided design of chimeric receptor binding proteins","author":"Dunne","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.copbio.2020.09.005_bib0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2019.09.015","article-title":"Engineering phage host-range and suppressing bacterial resistance through phage tail fiber mutagenesis","author":"Yehl","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.copbio.2020.09.005_bib0150","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/antibiotics8030138","article-title":"Bacteriophages as alternatives to antibiotics in clinical care","volume":"8","author":"Romero-Calle","year":"2019","journal-title":"Antibiotics"},{"key":"10.1016\/j.copbio.2020.09.005_bib0155","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1472-765X.2003.01400.x","article-title":"Genetically modified filamentous phage as bactericidal agents: a pilot study","volume":"37","author":"Hagens","year":"2003","journal-title":"Lett Appl Microbiol"},{"key":"10.1016\/j.copbio.2020.09.005_bib0160","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1128\/AAC.48.10.3817-3822.2004","article-title":"Therapy of experimental pseudomonas infections with a nonreplicating genetically modified phage","volume":"48","author":"Hagens","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.copbio.2020.09.005_bib0165","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/1471-2180-11-195","article-title":"Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection","volume":"11","author":"Paul","year":"2011","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.copbio.2020.09.005_bib0170","doi-asserted-by":"crossref","DOI":"10.1038\/nbt.3043","article-title":"Exploiting CRISPR-cas nucleases to produce sequence-specific antimicrobials","author":"Bikard","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.copbio.2020.09.005_bib0175","doi-asserted-by":"crossref","DOI":"10.1038\/nbt.3011","article-title":"Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases","author":"Citorik","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.copbio.2020.09.005_bib0180","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1500107112","article-title":"Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria","author":"Yosef","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.copbio.2020.09.005_bib0185","doi-asserted-by":"crossref","first-page":"11197","DOI":"10.1073\/pnas.0704624104","article-title":"Dispersing biofilms with engineered enzymatic bacteriophage","volume":"104","author":"Lu","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.copbio.2020.09.005_bib0190","doi-asserted-by":"crossref","first-page":"5340","DOI":"10.1128\/AEM.01434-14","article-title":"Inhibition of biofilm formation by T7 bacteriophages producing quorum-quenching enzymes","volume":"80","author":"Pei","year":"2014","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.copbio.2020.09.005_bib0195","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1016\/j.biomaterials.2012.03.054","article-title":"Engineered phage-based therapeutic materials inhibit Chlamydia trachomatis intracellular infection","volume":"33","author":"Bhattarai","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.copbio.2020.09.005_bib0200","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1128\/AEM.05741-11","article-title":"Reversing bacterial resistance to antibiotics by phage-mediated delivery of dominant sensitive genes","volume":"78","author":"Edgar","year":"2012","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.copbio.2020.09.005_bib0205","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1073\/pnas.0800442106","article-title":"Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy","volume":"106","author":"Lu","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.copbio.2020.09.005_bib0210","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/nm0912-1318","article-title":"Turning a new phage","volume":"18","author":"Gravitz","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.copbio.2020.09.005_bib0215","first-page":"7","article-title":"Silk route to the acceptance and re-implementation of bacteriophage therapy\u2014Part II","author":"Sybesma","year":"2018","journal-title":"Antibiotics"},{"key":"10.1016\/j.copbio.2020.09.005_bib0220","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3389\/fmicb.2020.00883","article-title":"Deciphering the role of holin in mycobacteriophage D29 physiology","volume":"11","author":"Bavda","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.copbio.2020.09.005_bib0225","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1128\/JB.01519-10","article-title":"Functional analysis of the Holin-Like proteins of mycobacteriophage Ms6","volume":"193","author":"Catal\u00e3o","year":"2011","journal-title":"J Bacteriol"},{"key":"10.1016\/j.copbio.2020.09.005_bib0230","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/1574-6968.12171","article-title":"Application of BRED technology to construct recombinant D29 reporter phage expressing EGFP","volume":"344","author":"da Silva","year":"2013","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.copbio.2020.09.005_bib0235","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/mmi.12210","article-title":"Functional requirements for bacteriophage growth: gene essentiality and expression in mycobacteriophage giles","volume":"88","author":"Dedrick","year":"2013","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.copbio.2020.09.005_bib0240","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1128\/AEM.01016-13","article-title":"Generation of affinity-tagged fluoromycobacteriophages by mixed assembly of phage capsids","volume":"79","author":"Piuri","year":"2013","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.copbio.2020.09.005_bib0245","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1751-7915.2011.00292.x","article-title":"Bacteriophage recombineering in the lytic state using the lambda red recombinases","volume":"5","author":"Feh\u00e9r","year":"2012","journal-title":"Microb Biotechnol"},{"key":"10.1016\/j.copbio.2020.09.005_bib0250","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.1128\/AEM.00911-10","article-title":"Recombineering using RecTE from Pseudomonas syringae","volume":"76","author":"Swingle","year":"2010","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.copbio.2020.09.005_bib0255","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1073\/pnas.0709089105","article-title":"Identification and analysis of recombineering functions from Gram-negative and Gram-positive bacteria and their phages","volume":"105","author":"Datta","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.copbio.2020.09.005_bib0260","first-page":"3","article-title":"Exploring optimization parameters to increase ssDNA recombineering in Lactococcus lactis and Lactobacillus reuteri","author":"van Pijkeren","year":"2012","journal-title":"Bioengineered"},{"key":"10.1016\/j.copbio.2020.09.005_bib0265","first-page":"42","article-title":"CRISPR-Cas 9-assisted recombineering in Lactobacillus reuteri","author":"Oh","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.copbio.2020.09.005_bib0270","series-title":"FEMS Immunology and Medical Microbiology","first-page":"113","article-title":"A rapid and simple method for inactivating chromosomal genes in Yersinia","author":"Derbise","year":"2003"},{"key":"10.1016\/j.copbio.2020.09.005_bib0275","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1574-695X.2006.00118.x","article-title":"Developing live Shigella vaccines using \u03bb red recombineering","volume":"47","author":"Ranallo","year":"2006","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.copbio.2020.09.005_bib0280","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2199-10-34","article-title":"Use of the lambda Red-recombineering method for genetic engineering of Pantoea ananatis","volume":"10","author":"Katashkina","year":"2009","journal-title":"BMC Mol Biol"},{"key":"10.1016\/j.copbio.2020.09.005_bib0285","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2199-9-20","article-title":"Use of the lambda Red recombinase system to rapidly generate mutants in Pseudomonas aeruginosa","volume":"9","author":"Lesic","year":"2008","journal-title":"BMC Mol Biol"},{"key":"10.1016\/j.copbio.2020.09.005_bib0290","doi-asserted-by":"crossref","first-page":"15264","DOI":"10.1073\/pnas.261348198","article-title":"Epitope tagging of chromosomal genes in Salmonella","volume":"98","author":"Uzzau","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.copbio.2020.09.005_bib0295","article-title":"Phage therapy for limb-threatening prosthetic knee Klebsiella pneumoniae infection: case report and in vitro characterization of anti-biofilm activity","author":"Cano","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.copbio.2020.09.005_bib0300","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/emph\/eoy005","article-title":"Phage treatment of an aortic graft infected with Pseudomonas aeruginosa","volume":"2018","author":"Chan","year":"2018","journal-title":"Evol Med public Heal"},{"key":"10.1016\/j.copbio.2020.09.005_bib0305","first-page":"61","article-title":"Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection","author":"Schooley","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.copbio.2020.09.005_bib0310","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3389\/fcimb.2018.00376","article-title":"Bacteriophage therapy: clinical trials and regulatory hurdles","volume":"8","author":"Furfaro","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.copbio.2020.09.005_bib0315","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1473-3099(18)30482-1","article-title":"Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1\/2 trial","volume":"19","author":"Jault","year":"2019","journal-title":"Lancet Infect"},{"key":"10.1016\/j.copbio.2020.09.005_sbref0320","first-page":"11","article-title":"Current state of compassionate phage therapy","author":"McCallin","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.copbio.2020.09.005_bib0325","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ebiom.2015.12.023","article-title":"Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh","volume":"4","author":"Sarker","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.copbio.2020.09.005_bib0330","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1749-4486.2009.01973.x","article-title":"A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy","volume":"34","author":"Wright","year":"2009","journal-title":"Clin Otolaryngol"}],"container-title":["Current Opinion in Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958166920301282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958166920301282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:17:01Z","timestamp":1778566621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0958166920301282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":66,"alternative-id":["S0958166920301282"],"URL":"https:\/\/doi.org\/10.1016\/j.copbio.2020.09.005","relation":{},"ISSN":["0958-1669"],"issn-type":[{"value":"0958-1669","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic manipulation of phages for therapy using BRED","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.copbio.2020.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}